特刊：COVID-19 与血栓
Special Issue "COVID-19 and Thrombosis".
机构信息
Uoc Medicina, P.O. A. Rizzoli-Asl Na2 Nord, Lacco Ameno, 80076 Naples, Italy.
General Medicinem, Thrombotic and Haemorragic Unit, Department of Internal Medicine, University of Messina, 98122 Messina, Italy.
出版信息
Viruses. 2022 Jun 29;14(7):1425. doi: 10.3390/v14071425.
Abstract
Since the pandemic began, an association among COVID-19 and venous thromboembolism has been reported, in particular for inpatients [...].
摘要
自疫情开始以来，已报告 COVID-19 与静脉血栓栓塞之间存在关联，尤其是在住院患者中[... ]。
相似文献
1
Special Issue "COVID-19 and Thrombosis".特刊：COVID-19 与血栓
Viruses. 2022 Jun 29;14(7):1425. doi: 10.3390/v14071425.
2
Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.COVID-19 相关静脉血栓栓塞症：已报告风险和现行指南的系统综述。
Swiss Med Wkly. 2020 Jun 21;150:w20301. doi: 10.4414/smw.2020.20301. eCollection 2020 Jun 15.
3
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.COVID-19 患者接受抗栓治疗时的静脉血栓栓塞症的系统评估：发生率和 D-二聚体作为预测因素的作用。
J Thromb Thrombolysis. 2020 Jul;50(1):211-216. doi: 10.1007/s11239-020-02146-z.
4
COVID-19 and its implication for venous thromboembolism.新型冠状病毒肺炎及其对静脉血栓栓塞症的影响。
Cardiol J. 2020;27(5):481-484. doi: 10.5603/CJ.2020.0153.
5
Review of article: Porfidia, A., Valeriani, E., Pola, R., Porreca, E., Rutjes, A.W.S., Di Nisio, M. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thrombosis Research. 2020;196:67-74.文章综述：波尔菲迪亚，A.，瓦莱里亚尼，E.，波拉，R.，波雷卡，E.，鲁杰斯，A.W.S.，迪尼西奥，M. 新型冠状病毒肺炎患者的静脉血栓栓塞症：系统评价和荟萃分析。《血栓形成研究》。2020年；196：67 - 74。
J Vasc Nurs. 2020 Dec;38(4):193-194. doi: 10.1016/j.jvn.2020.11.002.
6
[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].[阿根廷COVID-19住院患者血栓预防用药建议]
Medicina (B Aires). 2020;80 Suppl 3:65-66.
7
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19.D-二聚体及中等剂量预防措施在COVID-19危重症患者静脉血栓栓塞中的应用价值
Thromb Res. 2020 Dec;196:222-226. doi: 10.1016/j.thromres.2020.08.027. Epub 2020 Aug 21.
8
Thromboinflammation as a Driver of Venous Thromboembolism.血栓炎症作为静脉血栓栓塞症的驱动因素。
Hamostaseologie. 2021 Dec;41(6):428-432. doi: 10.1055/a-1661-0257. Epub 2021 Dec 23.
9
Contraceptive advice during COVID-19 pandemic and the overlapping threat of venous thromboembolism.2019冠状病毒病大流行期间的避孕建议以及静脉血栓栓塞的叠加风险
Eur J Obstet Gynecol Reprod Biol. 2021 May;260:232-233. doi: 10.1016/j.ejogrb.2021.03.011. Epub 2021 Mar 11.
10
COVID-19 and venous thromboembolism: part of a multisystem disease.COVID-19 和静脉血栓栓塞症：多系统疾病的一部分。
Rev Esp Enferm Dig. 2021 May;113(5):390. doi: 10.17235/reed.2021.7907/2021.
本文引用的文献
1
Molecular Cross-Talk between Integrins and Cadherins Leads to a Loss of Vascular Barrier Integrity during SARS-CoV-2 Infection.整合素与钙黏蛋白之间的分子串扰导致 SARS-CoV-2 感染期间血管屏障完整性丧失。
Viruses. 2022 Apr 25;14(5):891. doi: 10.3390/v14050891.
2
New Insights in the Occurrence of Venous Thromboembolism in Critically Ill Patients with COVID-19-A Large Postmortem and Clinical Analysis.新型冠状病毒肺炎危重症患者静脉血栓栓塞症发生的新认识——一项大型尸检及临床分析
Viruses. 2022 Apr 14;14(4):811. doi: 10.3390/v14040811.
3
Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study.住院 COVID-19 患者中强化剂量丁扎肝素：INTERACT 研究。
Viruses. 2022 Apr 7;14(4):767. doi: 10.3390/v14040767.
4
Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation.急性 COVID-19 肺炎住院非危重症患者接受预防剂量抗凝治疗的静脉血栓栓塞风险因素。
Viruses. 2022 Mar 31;14(4):737. doi: 10.3390/v14040737.
5
Coronary Stent Thrombosis in COVID-19 Patients: A Systematic Review of Cases Reported Worldwide.COVID-19 患者的冠状动脉支架血栓形成：全球报告病例的系统评价。
Viruses. 2022 Jan 27;14(2):260. doi: 10.3390/v14020260.
6
Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.针对 COVID-19 的凝血系统激活：抗凝剂、疫苗负载纳米颗粒以及 COVID-19 疫苗中高凝状态的见解。
Viruses. 2022 Jan 24;14(2):228. doi: 10.3390/v14020228.
7
The Role of Von Willebrand Factor in the Pathogenesis of Pulmonary Vascular Thrombosis in COVID-19.血管性血友病因子在 COVID-19 肺血管血栓形成发病机制中的作用。
Viruses. 2022 Jan 21;14(2):211. doi: 10.3390/v14020211.
8
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.多国静脉血栓栓塞症注册研究中，接种 SARS-CoV-2 疫苗后 30 天内的静脉血栓栓塞症。
Viruses. 2022 Jan 18;14(2):178. doi: 10.3390/v14020178.
9
Heparin and SARS-CoV-2: Multiple Pathophysiological Links.肝素与 SARS-CoV-2：多种病理生理学关联。
Viruses. 2021 Dec 11;13(12):2486. doi: 10.3390/v13122486.
10
Zotero 插件